Floatz logo

Procarbazine

Chronic Myeloproliferative Disorders

Indiana UniversitySmall moleculePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

20 Active assets in the Chronic Myeloproliferative Disorders cohort.

Asset / SponsorPhaseRating
Evomela
Center for International Blood and Marrow Transplant Research
Phase 2/3BBB
Fludarabine
Sawa Ito, MD
Phase 4BB
Busulphan
Sawa Ito, MD
Phase 4BB
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2/3BB
FILGRASTIM
City of Hope Medical Center
Phase 3BB

View all 50 →

Same molecule, other indications

Procarbazine is also rated in:

central nervous system neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
lymphomaDormant
BB
Indicative ·
69 / 100
View asset →
Adult Giant Cell GlioblastomaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →